EMA Head Calls For New Global Workshop On Variant Vaccines
Almost 1 Billion Vaccine Doses Distributed In EU
Executive Summary
Five vaccines and six therapeutics are now available for use against COVID-19 in the EU, but as Omicron shows, there is likely to be a need for new kinds of vaccines against future virus variants.
You may also be interested in...
EMA: Multiple COVID-19 Booster Programs ‘Not Sustainable’ In Long Term
Global regulators have been discussing how best to approach vaccination in the face of possible future coronavirus variants, and whether bivalent or multivalent vaccines could be the answer.
Nuvaxovid COVID-19 Vaccine Wins EU Approval
Initial doses of Novavax’s vaccine are expected to arrive in Europe in January.
Novel Sickle Cell Treatment Among 13 New Drugs On Track For EU Approval
A first-of-its-kind drug for uterine fibroids and a new monoclonal antibody treatment for COVID-19 are among several new drugs recommended for pan-EU approval this month.